Abstract: In July 2023, the American Heart Association (AHA), the American College of Cardiology (ACC), and four other professional societies jointly released the updated version of the AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Artery Disease. This guideline emphasizes a patient-centered and team-based approach to the overall management of chronic coronary artery disease (CCD), highlights the impact of lifestyle improvements on the prognosis of CCD patients, and provides new insights into risk assessment for major adverse cardiovascular events (MACE) and recommendations for novel medications. These updates hold significant guiding value for health care professionals in China to provide high-quality management for CCD patients.